low cost/easy to use treatments, higher bioavailability, improved compliance, preservative-free, less side effects, complete solutions, non-invasive.
For Eye Care Professionals
low risk, non-invasive treatment choices, better patient outcomes, predictable treatment plans, fewer complications due to reduced side effect profiles, customized prescriptions, higher patient satisfaction, beneficial economics.
low cost/high quality products, low capital investment, reduced regulatory complexities, patent protection, first in market, deep pipeline of products.
cost neutrality (versus prescription eye drops), more satisfied members and providers.